Skip to content

Organogenesis Holdings Inc. ORGO Change In Purchases Of Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities

Change In Purchases Of Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities at other companies

Gentex logo
GentexGNTX
-$2.89M-130%
N-able logo
N-ableNABL
$3.02M+10,314%
Calix logo
CalixCALX
$985.75K+715%
Helmerich & Payne logo
Helmerich & PayneHP
$3.9M
Calix logo
CalixCALX
$985.75K+715%
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
$959K+35.6%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept orgo:ChangeInPurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s change in purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s change in purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities?
Organogenesis Holdings Inc. (ORGO) reported change in purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities of $39K in Q1 2026.
How has Organogenesis Holdings Inc.'s change in purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities changed year-over-year?
Organogenesis Holdings Inc.'s change in purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities decreased by 77.3% year-over-year, from $172K to $39K.
What does change in purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities mean?
This metric captures the change in capital expenditure liabilities that have been accrued but not yet paid in cash. It provides visibility into the timing differences between the commitment to purchase assets and the actual cash outflow. This is essential for reconciling cash flow from operations with capital investment activities.